Predictive utility of blood pressure, waist circumference and body mass index for metabolic syndrome in patients with schizophrenia in Singapore

被引:6
作者
Nurjono, Milawaty [1 ]
Lee, Jimmy [1 ,2 ]
机构
[1] Inst Mental Hlth, Div Res, Singapore 539747, Singapore
[2] Inst Mental Hlth, Dept Gen Psychiat, Singapore 539747, Singapore
基金
英国医学研究理事会;
关键词
blood pressure; body mass index (BMI); metabolic syndrome; schizophrenia; waist circumference; CARDIOVASCULAR RISK; CENTRAL OBESITY; MORTALITY; SMOKING; IMPACT;
D O I
10.1111/j.1751-7893.2012.00384.x
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Aims This study aims to examine and compare the predictive utility of blood pressure (BP), waist circumference (WC) and body mass index (BMI), and to determine optimal cut-off values in prediction of metabolic syndrome (MetS) in patients with chronic schizophrenia. Methods About 100 patients with chronic schizophrenia were recruited. BMI and BP were measured and laboratory tests to evaluate patients' high-density lipoprotein cholesterol, triglycerides and glucose levels were performed. Presence of MetS was examined according to AHA/NHLBI guidelines. Predictive utility of BP, WC and BMI was examined using receiver operating curve and discriminant indices were determined accordingly. Results Forty-six (46%) patients were identified to have MetS. BMI of 23kgm2 was most accurate (AUC=0.83, P<0.001), with sensitivity of 93.5%, specificity of 48.1%, positive predictive value of 60.6% and negative predictive value of 92.9% in identifying MetS. Conclusion This finding has immediate and significant clinical implications in the local population with schizophrenia.
引用
收藏
页码:205 / 209
页数:5
相关论文
共 25 条
  • [1] Mortality in schizophrenia
    Auquier, Pascal
    Lancon, Christophe
    Rouillon, Frederic
    Lader, Malcolm
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (12) : 1308 - 1312
  • [2] Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies
    Barba, C
    Cavalli-Sforza, T
    Cutter, J
    Darnton-Hill, I
    Deurenberg, P
    Deurenberg-Yap, M
    Gill, T
    James, P
    Ko, G
    Miu, AH
    Kosulwat, V
    Kumanyika, S
    Kurpad, A
    Mascie-Taylor, N
    Moon, HK
    Nishida, C
    Noor, MI
    Reddy, KS
    Rush, E
    Schultz, JT
    Seidell, J
    Stevens, J
    Swinburn, B
    Tan, K
    Weisell, R
    Wu, ZS
    Yajnik, CS
    Yoshiike, N
    Zimmet, P
    [J]. LANCET, 2004, 363 (9403) : 157 - 163
  • [3] Statistics review 13: Receiver operating characteristic curves
    Bewick, V
    Cheek, L
    Ball, J
    [J]. CRITICAL CARE, 2004, 8 (06): : 508 - 512
  • [4] Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: An analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort
    Bobes, Julio
    Arango, Celso
    Garcia-Garcia, Margarida
    Rejas, Javier
    [J]. SCHIZOPHRENIA RESEARCH, 2010, 119 (1-3) : 101 - 109
  • [5] Twenty-five year mortality of a community cohort with schizophrenia
    Brown, Steve
    Kim, Miranda
    Mitchell, Clemence
    Inskip, Hazel
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2010, 196 (02) : 116 - 121
  • [6] Clinicians' recognition of the metabolic adverse effects of antipsychotic medications
    Buckley, PF
    Miller, DD
    Singer, B
    Arena, J
    Stirewalt, EM
    [J]. SCHIZOPHRENIA RESEARCH, 2005, 79 (2-3) : 281 - 288
  • [7] Metabolic syndrome and left ventricular hypertrophy in the prediction of cardiovascular events: The Strong Heart Study
    de Simone, G.
    Devereux, R. B.
    Chinali, M.
    Roman, M. J.
    Lee, E. T.
    Resnick, H. E.
    Howard, B. V.
    [J]. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2009, 19 (02) : 98 - 104
  • [8] Medical morbidity and mortality in schizophrenia: Guidelines for psychiatrists
    Goff, DC
    Cather, C
    Evins, AE
    Henderson, DC
    Freudenreich, O
    Copeland, PM
    Bierer, M
    Duckworth, K
    Sacks, FM
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (02) : 183 - 194
  • [9] Gough Stephen C L, 2005, J Psychopharmacol, V19, P47, DOI 10.1177/0269881105058380
  • [10] Metabolic Syndrome Associated with Schizophrenia and Atypical Antipsychotics
    Hasnain, Mehrul
    Fredrickson, Sonja K.
    Vieweg, W. Victor R.
    Pandurangi, Anand K.
    [J]. CURRENT DIABETES REPORTS, 2010, 10 (03) : 209 - 216